Genomic Characterization of Metformin Hepatic Response.
Metformin is used as a first-line therapy for type 2 diabetes (T2D) and prescribed for numerous other diseases. However, its mechanism of action in the liver has yet to be characterized in a systematic manner. To comprehensively identify genes and regulatory elements associated with metformin treatm...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-11-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5130177?pdf=render |